 |
|
|
| |
Safety and Antiviral Activity of MK-1439, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), In Treatment-Naïve HIV-Infected Patients
|
| |
| |
Reported by Jules Levin
CROI Atlanta March 3-6 2013
Matt S. Anderson1, Jocelyn Gilmartin1, Martine Robberechts2, Inge De Lepeleire2, Ernestina Tetteh1, Ying Guo1, Dirk Schurmann3, Frank Wagner4, John A. Wagner1, Joan R. Butterton1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ USA
2MSD Belgium, Brussels, Belgium
3Charite - Universitatsmedizin Berlin, Berlin, Germany
4Charite - Research Organisation, Berlin, Germany
|
| |
|
|
|
|
|
